Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • etal
    Member
    • Oct 2013
    • 23

    #1

    Tumor-only variant calling

    I'm attempting to call SNVs in tumor samples without a paired normal sample. Some of these tumor samples can have low purity, so the allelic frequency of somatic variants is much lower than the .5 expected for germline SNPs. FreeBayes in particular gives these variants an extremely low quality score, even with the --pooled-continuous model, making it difficult to usefully filter the resulting VCF.

    Does anyone know of a good SNV caller designed for single tumor samples? Foundation Medicine claims to have built one, but did not release it publicly.

    Failing that: Can I fudge FreeBayes' --ploidy or --cnv-map arguments based on known tumor purity so that it will model any fully clonal somatic SNVs properly?

    This workflow looks like:
    1. Infer copy number segments from mapped reads (CNVkit).
    2. Infer tumor purity from segments (THetA).
    3. Compute fake tumor-cell ploidy = (2 / tumor_purity). Example: sample is 20% tumor cells; a somatic, heterozygous SNV that is fully clonal in the tumor cells would have allele frequency .1, so fake ploidy is 10.
    4. Rescale CNV values to fake ploidy, so neutral copy number is the fake ploidy value (e.g. 10). Round to integers.
    5. Run FreeBayes with --cnv-map = rescaled CNVs. (Also --pooled-discrete, I suppose.)


    Would this allow FreeBayes to accurately call somatic variants with appropriate quality scores?

    Could the same be done with GATK UnifiedGenotyper or HaplotypeCaller, or samtools?
  • etal
    Member
    • Oct 2013
    • 23

    #2
    Mentioned in another thread:

    Originally posted by SNPsaurus View Post
    You might try LoFreq for calling rarer variants:
    Download LoFreq for free. Fast and sensitive variant-calling from sequencing data. None

    http://www.ncbi.nlm.nih.gov/pubmed/23066108
    I think this is the sort of variant caller I was looking for.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    37 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    41 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    45 views
    0 reactions
    Last Post SEQadmin2  
    Working...